Since its establishment, NORCE has sold several subsidiaries that have been started on the basis of results and innovations from our research. This has meant good liquidity for NORCE and we are well equipped for new research and innovative initiatives. Two of these companies, Gexcon and Prototech, were sold in 2021.
The research centre, the GenØk Centre for Biosafety in Tromsø became part of NORCE in December 2021. GenØk is a national centre for biosafety and conducts research on environmental, health and societal consequences of the use of genetic engineering and genetic modification. The centre focuses on the safe use of biotechnology.